154650-16-5

Basic information

• Product Name: 2-BROMO-6-FLUORO-3-METHYLBENZALDEHYDE
• Synonyms: 2-BROMO-6-FLUORO-3-METHYLBENZALDEHYDE;Benzaldehyde, 2-broMo-6-fluoro-3-Methyl-
• CAS NO: 154650-16-5
• Molecular Formula: C8H6BrFO
• Molecular Weight: 217.04
• EINECS: 1312995-182-4
• Mol File: 154650-16-5.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 248.1℃
• Flash Point: 103.9℃
• Appearance: /
• Density: 1.575
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• Sensitive: Air Sensitive
• CAS DataBase Reference: 2-BROMO-6-FLUORO-3-METHYLBENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-6-FLUORO-3-METHYLBENZALDEHYDE(154650-16-5)
• EPA Substance Registry System: 2-BROMO-6-FLUORO-3-METHYLBENZALDEHYDE(154650-16-5)

Safety Data

• Hazardous Substances Data: 154650-16-5(Hazardous Substances Data)

Usage

General Description

2-Bromo-6-fluoro-3-methylbenzaldehyde is a chemical compound with the molecular formula C8H6BrFO. It is a derivative of benzaldehyde, with bromine and fluorine substitutions on the 2 and 6 positions, and a methyl group attached to the 3 position. 2-BROMO-6-FLUORO-3-METHYLBENZALDEHYDE is often used in organic synthesis and as an intermediate in the production of pharmaceuticals and agrochemicals. Its distinctive structure and reactivity make it a valuable building block for creating more complex organic compounds through various chemical reactions. It is important to handle this compound with care, as it is a toxic substance and can cause skin and eye irritation.

Upstream product

• 1422-53-3 2-bromo-4-fluorotoluene 
• 68-12-2 N,N-dimethyl-formamide 
• 109-94-4 formic acid ethyl ester 

Downstream Products

• 1256483-11-0 C₉H₇BrFN 
• 1404115-67-8 C₁₄H₁₆FN₃O 
• 1404115-08-7 C₂₃H₂₂F₄N₄O₃ 
• 1404115-09-8 C₂₂H₂₀F₄N₄O₃ 
• 1056214-74-4 2-bromo-6-methoxy-3-methylbenzaldehyde 

Relevant articles and documents

Preparation method of 4-bromo-5-methyl-1H-indazole

The invention discloses a preparation method of 4-bromo-5-methyl-1H-indazole, wherein the preparation method comprises the specific steps: (1) reacting a compound (II) in the presence of lithium diisopropylamide to generate a lithium reagent, and reacting

INHIBITING HUMAN INTEGRIN α4β7

Disclosed are small molecule antagonists of human α4β7 integrin, and methods of using them to treat a number of diseases and conditions.

Dihydroisocoumarin derivative and preparation method and application thereof

The present invention discloses a dihydroisocoumarin derivative and preparation method and application thereof, the dihydroisocoumarin derivative having a structure as shown in formula (I) or (II). The method of preparing dihydroisocoumarin derivatives of